Artificial intelligence is beginning to outperform humans in narrow but economically consequential tasks, raising anxieties about job security and even agency. We are seriously discussing the possibility of losing control over AI. And one of the proposed ways of dealing with it is integration: linking the nervous system to digital tools through the brain-computer interfaces (BCIs).
Danish pharmaceutical company Novo Nordisk has filed a lawsuit against U.S.-based Hims & Hers Health for patent infringement, linked to the company’s attempt to bring to market a cheaper, compounded version of a semaglutide-based weight-loss pill — the key active ingredient in blockbuster products such as Wegovy and Ozempic.
Language models are widely capable of answering health-related questions — a topic that the media have covered extensively. These are truly remarkable advancements. However, the process of implementing them into real life rarely draws the same attention; it is accompanied by tedious paperwork and annoying safety issues.
A paperclip‑sized wireless sensor that tracks pressures inside the heart–lung circulation has been recommended by NICE for routine use across the NHS in England, in a move expected to shift heart‑failure management from hospital clinics to patients’ homes.
Modern medical practice is virtually unthinkable without numerous wearable electronic devices. Miniature flexible devices that continuously monitor blood glucose levels, blood pressure, pulse, or other vital parameters have become an integral part of daily life and an indispensable element of diagnostics and treatment.
Medtronic announced on February 3, 2026, its intent to exercise its option to acquire CathWorks, an Israeli medical device company specializing in AI-driven coronary artery disease diagnostics, in a deal valued at up to $585 million plus potential undisclosed earn-out payments. The acquisition, pending U.S. Federal Trade Commission clearance, is expected to close by the end of Medtronic’s fiscal year 2026.
A few weeks ago, the world’s largest annual consumer electronics exhibition — the Consumer Electronics Show (CES) 2026 — came to an end. CES 2026 delivered a parade of ambitious consumer tech: AI companions, advanced driver assistance, home humanoids, and smarter devices for everyday life. It’s impressive, yet at times the demos feel like a polished version of ideas we’ve already seen in speculative fiction, with just enough “Black Mirror” energy to make you pause.
Health tech was one of the most visible themes at CES 2026 — from smart diagnostics to wearable neurostimulation and at-home monitoring. These tools promise earlier insights and more personalized care, yet conspicuously resemblant of Black Mirror episodes: they listen, track, and interpret our daily lives in ways that conflate health monitoring with constant surveillance.